Blurbs

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), HCA Healthcare (HCA) and Universal Health (UHS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Eli Lilly & Co (LLYResearch Report), HCA Healthcare (HCAResearch Report) and Universal Health (UHSResearch Report).

Eli Lilly & Co (LLY)

In a report issued on July 22, David Risinger from SVB Securities maintained a Buy rating on Eli Lilly & Co. The company’s shares closed last Tuesday at $331.56, close to its 52-week high of $335.33.

According to TipRanks.com, Risinger is a 3-star analyst with an average return of 4.0% and a 72.2% success rate. Risinger covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Prometheus Biosciences, and Horizon Therapeutics.

Eli Lilly & Co has an analyst consensus of Strong Buy, with a price target consensus of $334.50, a 1.1% upside from current levels. In a report issued on July 8, Morgan Stanley also maintained a Buy rating on the stock with a $395.00 price target.

See the top stocks recommended by analysts >>

HCA Healthcare (HCA)

Mizuho Securities analyst Ann Hynes reiterated a Buy rating on HCA Healthcare on July 22 and set a price target of $210.00. The company’s shares closed last Tuesday at $203.94.

According to TipRanks.com, Hynes is a 5-star analyst with an average return of 9.0% and a 59.1% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Acadia Healthcare, and AmerisourceBergen.

HCA Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $231.90, a 16.9% upside from current levels. In a report issued on July 7, Truist Financial also maintained a Buy rating on the stock with a $208.00 price target.

Universal Health (UHS)

In a report issued on July 25, Whit Mayo from SVB Securities reiterated a Hold rating on Universal Health, with a price target of $103.00. The company’s shares closed last Tuesday at $109.36, close to its 52-week low of $98.63.

According to TipRanks.com, Mayo is a 5-star analyst with an average return of 9.0% and a 56.9% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Alignment Healthcare, and Privia Health Group.

Universal Health has an analyst consensus of Hold, with a price target consensus of $114.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on LLY:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos